Neurologic adverse events following influenza A (H1N1) vaccinations in children

Pediatrics International

Volumn 54, Issue 3, 2012, Pages 325-330

  Lee, Seung Jae ^a   Kim, Young Ok ^a   Woo, Young Jong ^a   Kim, Myeong Kyu ^a   Nam, Tai Seung ^a   Cho, Young Kuk ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

adverse effect; child; influenza A virus (H1N1 subtype); influenza vaccine

Indexed keywords

GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE;

ADOLESCENT; BELL PALSY; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DIZZINESS; DRUG INDUCED HEADACHE; FEMALE; FOLLOW UP; HUMAN; HYPOREFLEXIA; INFLUENZA A (H1N1); INFLUENZA VACCINATION; LIMB WEAKNESS; MALE; MEDICAL RECORD REVIEW; MONONEUROPATHY; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; PAIN; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SENSORY DYSFUNCTION; SKIN TINGLING; TREMOR; VACCINATION REACTION;

ADOLESCENT; CHILD; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MALE; NEUROTOXICITY SYNDROMES; RETROSPECTIVE STUDIES;

EID: 84861638012     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2012.03568.x     Document Type: Review

References (36)

1. Valdespino-Gomez JL, Garcia-Garcia L, de León-Rosales SP,. Vaccines against influenza A (H1N1) pandemic. Arch. Med. Res. 2009; 40: 693-704.
2. Vellozzi C, Broder KR, Haber P, et al,. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine 2010; 28: 7248-55.
3. Sejvar JJ, Kohl KS, Gidudu J, et al,. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011; 29: 599-612.
4. Choe YJ, Cho H, Bae GR, Lee JK,. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition. Vaccine 2011; 29: 2066-70.
5. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al,. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am. J. Epidemiol. 1979; 110: 105-23.
6. Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P,. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 2009; 27: 2114-20.
7. Haber P, DeStefano F, Angulo FJ, et al,. Guillain-Barré syndrome following influenza vaccination. JAMA 2004; 292: 2478-81.
8. Lasky T, Terracciano GJ, Magder L, et al,. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N. Engl. J. Med. 1998; 339: 1797-802.
9. Kaplan JE, Katona P, Hurwitz ES, Schonberger LB,. Guillain-Barre syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. JAMA 1982; 248: 698-700.
10. Hurwitz ES, Schonberger LB, Nelson DB, Holman RC,. Guillain-Barre syndrome and the 1978-1979 influenza vaccine. N. Engl. J. Med. 1981; 304: 1557-61.
11. Hughes RA, Charlton J, Latinovic R, Gulliford MC,. No association between immunization and Guillain-Barre Syndrome in the United Kingdom, 1992 to 2000. Arch. Int. Med. 2006; 166: 1301-4.
12. Juurlink DN, Stukel TA, Kwong J, et al,. Guillain- Barre Syndrome after influenza vaccination in adults: a population-based study. Arch. Int. Med. 2006; 166: 2217-21.
13. Greene SK, Kulldorff M, Lewis EM, et al,. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am. J. Epidemiol. 2010; 171: 177-88.
14. Piyasirisilp S, Hemachudha T,. Neurological adverse events associated with vaccination. Curr. Opin. Neurol. 2002; 15: 333-8.
15. Centers for Disease Control and Prevention (CDC). Safety of influenza A (H1N1) 2009 monovalent vaccines-United States, October 1-November 24, 2009. MMWR Morb. Mortal. Wkly Rep. 2009; 58: 1351-6.
16. Chou CH, Liou WP, Hu KI, Loh CH, Chou CC, Chen YH,. Bell's palsy associated with influenza vaccination: two case reports. Vaccine 2007; 25: 2839-41.
17. McMahon AW, Iskander J, Haber P, et al,. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003. Pediatrics 2005; 115: 453-60.
18. Rosenberg M, Sparks R, McMahon A, Iskander J, Campbell JD, Edwards KM,. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age. Vaccine 2009; 27: 4278-83.
19. Gross WL, Ravens KG, Hansen HW,. Meningoencephalitis syndrome following influenza vaccination. J. Neurol. 1978; 217: 219-22.
20. Nakamura N, Nokura K, Zettsu T, et al,. Neurologic complications associated with influenza vaccination: two adult cases. Intern. Med. 2003; 42: 191-4.
21. Brostoff JM, Beitverda Y, Birns J,. Post-influenza vaccine chronic inflammatory demyelinating polyneuropathy. Age. Ageing 2008; 37: 229-30.
22. Hull TP, Bates JH,. Optic neuritis after influenza vaccination. Am. J. Ophthalmol. 1997; 124: 703-4.
23. Hull JH, Mead SH, Foster OJ, Modarres-Sadeghi H,. Severe vasculitic neuropathy following influenza vaccination. J. Neurol. Neurosurg. Psychiatry 2004; 75: 1507-8.
24. Saito H, Yanagisawa T,. Acute cerebellar ataxia after influenza vaccination with recurrence and marked cerebellar atrophy. Tohoku J. Exp. Med. 1989; 158: 95-103.
25. Hambidge SJ, Glanz JM, France EK, et al,. Vaccine Safety Datalink Team. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA 2006; 296: 1990-7.
26. France EK, Glanz JM, Xu S, et al,. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch. Pediatr. Adolesc. Med. 2004; 158: 1031-6.
27. Korea centers for disease control and prevention: Division of VPD and NIP. 2009-2010 influenza A(H1N1) vaccination program in Korea. Public Health Wkly. Rep. 2010; 3: 357-60.
28. Compston A,. Aids to the investigation of peripheral nerve injuries. Medical Research Council: Nerve Injuries Research Committee. His Majesty's Stationery Office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with aids to the examination of the peripheral nervous system. By Michael O'Brien for the Guarantors of Brain. Saunders Elsevier: 2010; pp. [8] 64 and 94 Figures. Brain 2010; 133: 2838-44.
29. Fiore AE, Shay DK, Haber P, et al,. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) 2007. MMWR Morb. Mortal. Wkly Rep. 2007; 56: 1-60.
30. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M,. Safety and immunogenicity of an inactivated subvirion influenza a (H5N1) vaccine. N. Engl. J. Med. 2006; 354: 1343-51.
31. Izurieta HS, Haber P, Wise RP, et al,. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA 2005; 294: 2720-5.
32. Tremblay ME, Closon A, D'Anjou G, Bussières JF,. Guillain-Barré syndrome following H1N1 immunization in a pediatric patient. Ann. Pharmacother. 2010; 44: 1330-3.
33. Souayah N, Ajroud-Driss S, Sander HW, Brannagan TH, Hays HP, Chin RL,. Small fiber neuropathy following vaccination for rabies, varicella or Lyme disease. Vaccine 2009; 27: 7322-5.
34. Martyn CN, Hughes RA,. Epidemiology of peripheral neuropathy. J. Neurol. Neurosurg. Psychiatry 1997; 62: 310-8.
35. Mader R, Narendran A, Lewtas J, et al,. Systemic vasculitis following influenza vaccination-report of 3 cases and literature review. J. Rheumatol. 1993; 20: 1429-31.
36. Kelsall JT, Chalmers A, Sherlock CH, Tron VA, Kelsall AC,. Microscopic polyangiitis after influenza vaccination. J. Rheumatol. 1997; 24: 1198-202.